Mirum Pharmaceuticals (MIRM) Change in Cash (2019 - 2026)

Mirum Pharmaceuticals' Change in Cash history runs 8 years deep, the most recent figure standing at $28.5 million for Q1 2026.

• On a quarterly basis, Change in Cash rose 366.59% year-over-year to $28.5 million in Q1 2026; TTM through Mar 2026 was $114.4 million, a 226.27% increase from a year earlier, with the FY2025 full-year figure at $75.2 million, up 218.67% from the prior year.
• Change in Cash improved to $28.5 million in Q1 2026 per MIRM's latest filing, from $15.7 million in the prior quarter.
• Across five years, Change in Cash topped out at $147.8 million in Q2 2023 and bottomed at -$69.3 million in Q2 2024.
• The 5-year median for Change in Cash is $9.0 million (2022), against an average of $11.5 million.
• Across the five-year window, Change in Cash plunged 273.23% in 2024 and soared 3461.37% in 2025, its largest moves.
• Year by year, Change in Cash stood at -$7.8 million in 2022, then sank by 115.74% to -$16.7 million in 2023, then surged by 97.22% to -$466000.0 in 2024, then surged by 3461.37% to $15.7 million in 2025, then soared by 81.79% to $28.5 million in 2026.
• Per Business Quant, the three latest MIRM Change in Cash figures stand at $28.5 million (Q1 2026), $15.7 million (Q4 2025), and $53.9 million (Q3 2025).